Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d
iNKT cells are CD1d-restricted T cells recognizing lipid antigens. The prototypic iNKT cell-agonist α-galactosylceramide (α-GalCer) alongside compounds with similar structures induces robust proliferation and cytokine production of iNKT cells and protects against cancer in vivo. Monoclonal antibodie...
Main Authors: | Katharine Clark, Jessica Yau, Anja Bloom, Jing Wang, David J. Venzon, Motoshi Suzuki, Lise Pasquet, Benjamin J. Compton, Susanna L. Cardell, Steven A. Porcelli, Gavin F. Painter, Dirk M. Zajonc, Jay A. Berzofsky, Masaki Terabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02355/full |
Similar Items
-
Synthèse d’α-C-galactosylcéramides difluorés et évaluation de leurs propriétés immunorégulatrices pour le traitement des maladies autoimmunes systémiques
by: Colombel, Sophie
Published: (2012) -
Depletion of Thymus-Derived CD4+CD25+ T Cells Abrogates the Suppressive Effects of α-galactosylceramide Treatment on Experimental Allergic Conjunctivitis
by: Atsuki Fukushima, et al.
Published: (2008-01-01) -
Synthèse de nouveaux analogues C-glycosidiques d'alpha-galactosylcéramides : couplage des glycolipides à des anticorps spécifiques
by: Rouzier, Florian
Published: (2018) -
CD1d- and MR1-restricted T Cells in Sepsis
by: Peter A. Szabo, et al.
Published: (2015-08-01) -
The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines
by: Liu Y, et al.
Published: (2021-01-01)